FDA weighs regulatory approach for genAI medical devices - MobiHealthNews
Reported by MobiHealthNews · all stories from mobihealthnews.com
Editorial digest
The Food and Drug Administration is currently weighing different regulatory strategies for medical devices that incorporate generative artificial intelligence technology.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at MobiHealthNews →More like this
Other stories our editors tagged with the same themes.
- Reputable trade press8/19/2026
FDA Weighs Clinician-Style Tests for Generative AI Medical Devices - PYMNTS.com
FDA considers clinician-style evaluations for generative AI medical devices.
- Reputable trade press8/20/2026
FDA considers ‘competency-based’ evaluations for GenAI-enabled medical devices - MassDevice
The FDA is considering 'competency-based' evaluations for generative AI medical devices.
- Trusted health newsroom8/18/2026
FDA seeks feedback on potential regulatory approaches for generative AI-enabled medical devices | AHA News - American Hospital Association
The FDA seeks input on regulating generative AI for medical devices.
- Trusted health newsroom8/4/2026
STAT+: Are AI scribes medical devices? U.K. regulator weighs in
The U.K. regulator is evaluating AI scribes as medical devices.
- Trusted health newsroom9/3/2026
STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized
FDA pilot program allows generative AI devices to reach patients pre-authorization.
- Reputable trade press8/19/2026
Nearly All FDA-Cleared AI Medical Devices Lack Evidence of Patient Benefit - Inside Precision Medicine
Most FDA-approved AI medical devices lack strong evidence of direct patient benefit.